Kala Bio inc (KALA) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access KALA Annual Balance Sheets →
The table below presents a historical view of Kala Bio inc's balance sheet, supporting analysis of financial position trends.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2026)
(Mar 31 2026) (Dec 31 2025) (Sep 30 2025) (Jun 30 2025)
Assets
Cash & cash equivalent0.23
Short-term Investments, Total7.00
Cash & Short-term Investments7.00
Notes Receivable, Current0.21
Prepaid Expense And Other Assets Current0.00
Total Current Assets10.58
Equipment/Property/Plant Net0.00
Other Assets, Noncurrent3.14
Operating Lease Right Of Use Asset-
Total Assets10.58
Liabilities
Accounts Payable, Current AC1.14
Accrued Liabilities And Other Liabilities0.02
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current0.38
Business Combination, Contingent Consideration, Liability, Current BU0.00
Total Current Liabilities1.54
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Operating Lease Liability Current-
Total Liabilities1.54
Stockholders' Equity
Common Stock Value0.02
Additional Paid In Capital Common Stock707.13
Retained Earnings / Accumulated Deficit-698.10
Other Equity0.00
Common Stockholder's Equity9.04
Preferred Stockholder's Equity0.00
Total Stockholder's Equity9.04
Liabilities & Stockholder's Equity10.58
4 historic quarters locked

Sign in to unlock the full Kala Bio inc balance sheet history.

About Kala Bio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-098783

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.